Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals
- 6 October 2010
- journal article
- review article
- Published by Elsevier BV in Life Sciences
- Vol. 88 (21-22), 959-971
- https://doi.org/10.1016/j.lfs.2010.09.012
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxoneDrug and Alcohol Dependence, 2009
- Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4‐dimethyl‐benziso‐(2H)‐selenazine (ALT‐2074), an experimental catalytic mimic of glutathione oxidaseBritish Journal of Clinical Pharmacology, 2009
- Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activityDrug and Alcohol Dependence, 2009
- A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein functionBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Interaction between buprenorphine and atazanavir or atazanavir/ritonavirDrug and Alcohol Dependence, 2007
- Methadone-induced Torsade de pointes after stopping lopinavir–ritonavirEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Enantiomeric Metabolic Interactions and Stereoselective Human Methadone MetabolismJournal of Pharmacology and Experimental Therapeutics, 2007
- Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavirAIDS, 2006
- MDR- and CYP3A4-mediated drug–herbal interactionsLife Sciences, 2006
- Extrahepatic Metabolism of Drugs in HumansClinical Pharmacokinetics, 1994